EVO301

· Evommune, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EVO301, covering 2025-12-04 to 2025-12-04. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis [Phase 2]